Related Experiment Videos
US regulation of pharmaceutical outcomes research
1Evidence Review Branch, Division of Drug Marketing, Advertising and Communications, Food and Drug Administration, 5600 Fishers Lane, Mail Stop HFD-42, Rockville, MD 20857, USA. burkel@cder.fda.gov
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The patient-reported outcome (PRO) consortium: filling measurement gaps for PRO end points to support labeling claims.
Clinical pharmacology and therapeutics·2011
The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval.
Clinical pharmacology and therapeutics·2008
Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice.
Journal of the American Academy of Child and Adolescent Psychiatry·1999
Symptomatic cardiotoxicity associated with 5-fluorouracil.
Pharmacotherapy·1997
Need for uniform data elements in hospital drug use review.
American journal of hospital pharmacy·1981
Incorporating Equity Considerations Related to Financial Protection Through Extended Cost-Effectiveness Analysis: A Systematic Review.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
How Long Should We Wait? The Impact of Immature Data on Colorectal Cancer Decision Modeling.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
What Age is Appropriate for Self-Reporting EQ-5D-Y-3L? Chinese Insights from a Sample of Children Aged 6-11 years.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
How National Volume-Based Procurement Reshapes Drug Prices and Public Spending in China.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
A Simple Inequality of Opportunity Model for Guiding Resource Allocation in Health.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Cost-effectiveness of opportunistic salpingectomy during various non-gynecological abdominal surgeries for the prevention of tubo-ovarian carcinoma: results from a Markov Modelling study.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
[THE PHARMACEUTICAL HUMANITIES IN RUSSIA AND FOR RUSSIA].
Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny·2026
[The Role of Pharmaceutical Universities in Strengthening Japan's Drug Discovery Capabilities: A Pharmaceutical Industry Perspective].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026
A randomized, open-label, three-period, cross-over, single intravenous or intramuscular dose, pharmacokinetics and bioequivalence study of vitamin K1 in healthy adults.
Naunyn-Schmiedeberg's archives of pharmacology·2026
Academic Influence and Industry Funding in Platelet-Rich Plasma Injections: Coauthorship Network Analysis.
Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews·2026
Rupturing the Temporality of Pharmaceutical Patents: A Sketch for a New Temporal Economy of Pharmaceutical Markets.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2025